GGrantIndex
Sort

39,280 grants matching leukemia

Genetic and molecular basis for SRSF2 mutations in myelodysplasia

$644,704
Robert K Bradley · Fred Hutchinson Cancer Research Center · R01 · FY2016 · HL

Occupational Exposure Assessment

$644,691
Melissa Friesen · Division Of Cancer Epidemiology And Genetics · ZIA · FY2012 · CA

Humoral immunity after CAR-T cell therapy for B cell malignancies: The HICAR Study

$644,646
Joshua Aiden Hill · Fred Hutchinson Cancer Center · U01 · FY2023 · CA

Project 1: Chromosome Inheritance

$644,473
Bruce W Stillman · Cold Spring Harbor Laboratory · P01 · FY2022 · CA

Eastern Cooperative Oncology Group Chair's Office

$644,464
Robert L Comis · Drexel University · U10 · FY2007 · CA

O-Glycosylation of Epidermal Growth Factor-like Motifs

$644,447
Robert S. Haltiwanger · State University New York Stony Brook · R01 · FY2013 · GM

Genetic Predisposition to Chronic Lymphocytic Leukemia (CLL)

$644,443
Jennifer R Brown · Dana-Farber Cancer Inst · R01 · FY2022 · CA

Project 5

$644,371
Scott W Lowe · Cold Spring Harbor Laboratory · P01 · FY2016 · CA

Brain Tumors - Immunological and Biological Studies

$644,338
Duke University · R37 · FY2005 · CA

DETERMINANTS OF THE SECULAR INCREASE IN NHL

$644,289
Statens Serum Institut · R01 · FY2000 · CA

Interactions of retroviral and host proteins guided by advanced modeling

$644,288
Monica J Roth · Rutgers Biomedical And Health Sciences · R35 · FY2023 · GM

Lentiviral Gene Therapy and Genome Editing for Wiskott-Aldrich Syndrome

$644,283
David J Rawlings · St. Jude Children'S Research Hospital · P01 · FY2018 · HL

MICROFABRICATED INSTRUMENTATION TO MEASURE SPHINGOLIPID SIGNALING IN HUMAN ACUTE MYELOID LEUKEMIA

$644,104
Nancy L Allbritton · University Of Washington · R01 · FY2021 · CA

CORE C Technology Implementation/Development and Correlative Sciences

$644,007
Friederike Herbst-Nowrouzi · University Of Pennsylvania · P01 · FY2023 · CA

Dissecting and targeting canonical and non-canonical oncogenic functions of EZH2 in cancer

$643,960
G Greg Wang · Univ Of North Carolina Chapel Hill · R01 · FY2022 · CA

ITSC for Leukemia: Novel Molecular Strategies for NCTN: "Individualized" Therapie

$643,941
Clara D Bloomfield · Ohio State University · U10 · FY2017 · CA

Exposure to per- and polyfluoroalkyl substances (PFAS) and risk of cancer in children

$643,900
Catherine Metayer · University Of California Berkeley · R01 · FY2021 · ES

Intestinal tissue intrinsic mechanisms in regulation of GI GVHD

$643,890
Pavan Reddy · Baylor College Of Medicine · R01 · FY2024 · AI

Biochemical Mechanisms of Neural Plasticity

$643,879
Danny G Winder · Vanderbilt University · R01 · FY2019 · MH

Biochemical Mechanisms of Neural Plasticity

$643,879
John David Sweatt · Vanderbilt University · R01 · FY2017 · MH

Who Cares For Older Breast Cancer Surivors And How Does It Affect Quality?

$643,828
Jeanne Mandelblatt · Georgetown University · R01 · FY2010 · CA

BAFF-R CAR T cell therapy for ALL

$643,742
Larry W Kwak · Beckman Research Institute/City Of Hope · R01 · FY2024 · CA

Synthetic rescue of antigen-driven T cells and alloimmunity

$643,676
Yi Zhang · Temple Univ Of The Commonwealth · R01 · FY2020 · AI

Project 2: Microenvironmental and inflammatory mechanisms in MDM4-driven AML pathogenesis.

$643,607
Ulrich Steidl · Columbia University Health Sciences · P01 · FY2024 · CA

Viral Noncoding RNAs and Cell Transformation

$643,517
Joan A. Steitz · Yale University · R01 · FY2022 · CA